Cargando…

Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE

BACKGROUND: PULSE was a large, observational, multicenter study designed to evaluate the efficacy and safety of agomelatine in the treatment of major depression in patients with cardiovascular disease (CVD). METHODS: Patients with mild-to-moderate major depressive episodes, without psychotic symptom...

Descripción completa

Detalles Bibliográficos
Autor principal:	Medvedev, Vladimir E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407453/ https://www.ncbi.nlm.nih.gov/pubmed/28461750 http://dx.doi.org/10.2147/NDT.S129793

Ejemplares similares

Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study
por: Ivanov, Stanislav V, et al.
Publicado: (2014)

Efficacy and tolerability of agomelatine in the treatment of depression
por: Plesničar, Blanka Kores
Publicado: (2014)

Agomelatine for postpartum depression and breastfeeding
por: Xiao, Le
Publicado: (2021)

Agomelatine: The evidence for its place in the treatment of depression
por: Eser, Daniela, et al.
Publicado: (2010)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak, Jan, et al.
Publicado: (2013)

Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks
por: Gahr, Maximilian
Publicado: (2014)

Agomelatine and its therapeutic potential in the depressed patient
por: Kennedy, Sidney H, et al.
Publicado: (2007)

Agomelatine in Standard Medical Practice in Depressed Patients: Results of a 1-Year Multicentre Observational Study In France
por: Gorwood, Philip, et al.
Publicado: (2020)

Agomelatine: relief ensured at each and every stage of depression
por: Möller, Hans-Jurgen
Publicado: (2010)

Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder
por: Huang, Juan, et al.
Publicado: (2023)

Efficacy and safety of agomelatine in the treatment of patients with depressive disorder: A meta-analysis
por: Guo, Yue-Han, et al.
Publicado: (2023)

Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting
por: Lee, Kyung Ho, et al.
Publicado: (2023)

Involvement of the IL-6 Signaling Pathway in the Anti-Anhedonic Effect of the Antidepressant Agomelatine in the Chronic Mild Stress Model of Depression
por: Rossetti, Andrea C., et al.
Publicado: (2022)

Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece
por: Maniadakis, Nikos, et al.
Publicado: (2013)

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]
Publicado: (2013)

Agomelatine Softens Depressive-Like Behavior through the Regulation of Autophagy and Apoptosis
por: Chen, Fengpei, et al.
Publicado: (2021)

Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms
por: Martinotti, Giovanni, et al.
Publicado: (2016)

Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease
por: Chen, Jian-wei, et al.
Publicado: (2018)

Acute Hepatitis Due to Agomelatine Use in Elderly Women with Depression: Case Series
por: Chang, Cheng-Chen, et al.
Publicado: (2021)

Combination of agomelatine and bupropion for treatment-resistant depression: results from a chart review study including a matched control group
por: Sühs, Kurt-Wolfram, et al.
Publicado: (2015)

Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses
por: Gaziano, Liam, et al.
Publicado: (2022)

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
por: Howland, Robert H
Publicado: (2009)

Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010)

Agomelatine Efficacy in the Night Eating Syndrome
por: Milano, Walter, et al.
Publicado: (2013)

Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study
por: Fornaro, Michele, et al.
Publicado: (2013)

A Multicenter, Randomized, Controlled Trial of Electroacupuncture for Perimenopause Women with Mild-Moderate Depression
por: Li, Sheng, et al.
Publicado: (2018)

The effects of agomelatine and imipramine on liver cytochrome P450 during chronic mild stress (CMS) in the rat
por: Haduch, Anna, et al.
Publicado: (2020)

Successful Treatment with Agomelatine in NES: A Series of Five Cases
por: Milano, W., et al.
Publicado: (2013)

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
por: Levitan, Michelle Nigri, et al.
Publicado: (2015)

Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
por: Wang, Sheng-Min, et al.
Publicado: (2020)

Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2023)

Agomelatine: a potential novel approach for the treatment of memory disorder in neurodegenerative disease
por: Su, Qiang, et al.
Publicado: (2022)

The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia
por: Wang, Carol Sheei-Meei, et al.
Publicado: (2022)

The Changes of Expression and Methylation of Genes Involved in Oxidative Stress in Course of Chronic Mild Stress and Antidepressant Therapy with Agomelatine
por: Wigner, Paulina, et al.
Publicado: (2020)

Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
por: Avedisova, Alla, et al.
Publicado: (2009)

A multicenter, randomized controlled study on the efficacy of agomelatine in ameliorating anhedonia, reduced motivation, and circadian rhythm disruptions in patients with major depressive disorder (MDD)
por: Guo, Ping, et al.
Publicado: (2023)

The Effects of Agomelatine Treatment on Lipopolysaccharide-Induced Septic Lung Injuries in Rats
por: Köse, Duygu, et al.
Publicado: (2021)

Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression
por: De Berardis, Domenico, et al.
Publicado: (2015)

Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial
por: Shokrani, Marjan, et al.
Publicado: (2023)

Effect of cognitive retraining treatment in mild to moderate depressive disorders
por: Gupta, Aarzoo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_25t30dhd1073lqcfcj14b6gu5u